Evidence map›Paper›PMID 42304106›Full record

ArticleEMBO molecular medicine2026

Skin-derived G-CSF activates pathological granulopoiesis upon psoriasis.

Tomson Kosasih, Tatsuya Morishima, Sohyeon Lee, Jungyeon Yoon, Kanako Wakahashi, Pilhan Kim, Aiko Sada, Hitoshi Takizawa

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomson KosasihLaboratory of Stem Cell Stress, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-811, Japan.ORCID 0000-0002-2396-9960
Tatsuya MorishimaLaboratory of Stem Cell Stress, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-811, Japan.ORCID 0000-0003-3876-3217
Sohyeon LeeIVIM Technology Inc., Daejeon, 34013, Republic of Korea.
Jungyeon YoonIVIM Technology Inc., Daejeon, 34013, Republic of Korea.
Kanako WakahashiLaboratory of Stem Cell Stress, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-811, Japan.ORCID 0009-0001-8300-5100
Pilhan KimIVIM Technology Inc., Daejeon, 34013, Republic of Korea.ORCID 0000-0001-8388-1840
Aiko SadaDivision of Skin Regeneration and Aging, Medical Institute of Bioregulation (MIB), Kyushu University, Fukuoka, 812-8582, Japan.ORCID 0000-0002-0984-4280
Hitoshi TakizawaLaboratory of Stem Cell Stress, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-811, Japan. htakizawa@kumamoto-u.ac.jp.ORCID 0000-0002-5276-5430

Funding

JST FOREST JPMJFR200OMEXT | Japan Society for the Promotion of Science (JSPS) 21KK0150,21H02953 and 22K19548The National Research Foundation of Korea RS-2024-00407383 and RS-2025-00516548
6 · The paper itself

Abstract

Psoriasis is an inflammatory skin disease initiated by environmental triggers and driven by disruption of T cell cytokine network in the cutaneous milieu. The fact that complete resolution of disease by targeting the key inflammatory cytokines remains challenging indicates a contribution of other immune cells to the pathogenesis. Here, we study the role of neutrophils in psoriasis, the first-line innate immune defender that is short-lived but mobile and infiltrative into various tissues. We found that upon psoriasis induction, skin-resident endothelial cells are activated to produce G-CSF which contributes to emergency granulopoiesis in bone marrow and cutaneous accumulation of inflammatory neutrophils. Depletion of neutrophils or blockage of psoriasis-driven granulopoiesis by respective neutralizing antibodies lead to the reduction of cutaneous neutrophil burden and mitigates psoriasis pathogenesis. This mechanism appears to be conserved in human psoriasis, confirmed by public RNA-seq database reanalysis. Our findings uncovered and detailed the pathological crosstalk between skin and BM in psoriatic inflammation, proposing a potential therapeutic approach targeting cross-organ communication.

Indexed as

Granulocyte Colony-Stimulating FactorGranulocytesPsoriasisSkinAnimalsEndothelial CellsHumansMiceNeutrophilsGranulocyte Colony-Stimulating Factor

Identifiers

PMID42304106
PMCPMC13365241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.